www.fdanews.com/articles/68146-transport-glaxosmithkline-in-herpes-treatment-deal
Transport, GlaxoSmithKline in Herpes Treatment Deal
January 28, 2005
Framingham-Mass. based Transport Pharmaceuticals signed a license and collaboration
agreement with pharmaceutical giant GlaxoSmithKline for Transport's iontophoretic
device/drug combination system for the delivery of acyclovir, an approved cold-sore
(herpes labialis) treatment.
Mass
High Tech